Keun-Sik Hong
Quick facts
Marketed products
- Experimental: Rosuvastatin/Ezetimibe 10 · Cardiovascular
This combination reduces LDL cholesterol by inhibiting HMG-CoA reductase (rosuvastatin) and blocking intestinal cholesterol absorption (ezetimibe).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: